Anticlotting Drug From Genetically Engineered Goats Is Safe Says FDA Panel - USA
An expert panel that advises the US Food and Drug Adminstration (FDA) voted that the anti-clotting drug ATryn, which is made from the milk of genetically engineered goats, is safe and effective and be approved for the treatment of people with a rare inherited disorder that makes them susceptible to life-threatening blood clots. The drug, which is made by the biotechnology company GTC Biotherapeutics Inc based in Massachusetts, is already approved in Europe.